BIOMARIN PHARMACEUTICAL INC Acquisitions, Net of Cash Acquired
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2019-02-28
- BIOMARIN PHARMACEUTICAL INC payments to acquire businesses, net of cash acquired for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC payments to acquire businesses, net of cash acquired for the quarter ending 2017-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC payments to acquire businesses, net of cash acquired for the quarter ending 2016-12-31 was $1.32M.
- BIOMARIN PHARMACEUTICAL INC payments to acquire businesses, net of cash acquired for the quarter ending 2016-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC payments to acquire businesses, net of cash acquired for fiscal 2018 was $0.00.
- BIOMARIN PHARMACEUTICAL INC payments to acquire businesses, net of cash acquired for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- BIOMARIN PHARMACEUTICAL INC payments to acquire businesses, net of cash acquired for fiscal 2016 was $2.79M, a 99.48% decline from fiscal 2015.
- BIOMARIN PHARMACEUTICAL INC payments to acquire businesses, net of cash acquired for fiscal 2015 was $538.39M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $0.00 10-Q · filed 2017-10-31 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-02 | |||
| 2016-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.32M derived: sum of 2 quarters · filed 2019-02-28 | $2.79M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.47M 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | $1.47M 10-Q · filed 2017-08-02 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $0.00 derived: sum of 3 quarters · filed 2018-02-26 | $538.39M 10-K · filed 2018-02-26 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $538.39M 10-Q · filed 2016-11-03 | $538.39M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $538.39M 10-Q · filed 2016-08-08 | $538.39M derived: sum of 3 quarters · filed 2017-02-27 | $538.39M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $538.39M 10-Q · filed 2016-05-02 | $538.39M derived: sum of 2 quarters · filed 2017-02-27 | $538.39M derived: sum of 3 quarters · filed 2017-02-27 | $538.39M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 derived: sum of 2 quarters · filed 2017-02-27 | $0.00 derived: sum of 3 quarters · filed 2017-02-27 | $0.00 10-K · filed 2017-02-27 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $0.00 derived: sum of 2 quarters · filed 2014-10-28 | $0.00 10-Q · filed 2014-10-28 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-02 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $9.88M 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $0.00 derived: sum of 2 quarters · filed 2014-10-28 | $9.88M 10-Q · filed 2014-10-28 | $9.88M derived: sum of 4 quarters · filed 2014-10-28 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $9.88M 10-Q · filed 2014-07-31 | $9.88M derived: sum of 3 quarters · filed 2014-07-31 | $9.88M derived: sum of 4 quarters · filed 2014-07-31 |
| 2013-03-31 | $9.88M 10-Q · filed 2014-05-02 | $9.88M derived: sum of 2 quarters · filed 2014-05-02 | $9.88M derived: sum of 3 quarters · filed 2014-05-02 | $9.88M derived: sum of 4 quarters · filed 2014-05-02 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $0.00 derived: sum of 2 quarters · filed 2014-02-26 | $0.00 derived: sum of 3 quarters · filed 2014-02-26 | $0.00 10-K · filed 2014-02-26 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $0.00 derived: sum of 2 quarters · filed 2013-10-28 | $0.00 10-Q · filed 2013-10-28 | $0.00 derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $0.00 10-Q · filed 2013-07-29 | $0.00 derived: sum of 3 quarters · filed 2014-02-26 | $0.00 derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | $0.00 10-Q · filed 2013-04-29 | $0.00 derived: sum of 2 quarters · filed 2014-02-26 | $0.00 derived: sum of 3 quarters · filed 2014-02-26 | $0.00 derived: sum of 4 quarters · filed 2014-02-26 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $0.00 derived: sum of 2 quarters · filed 2014-02-26 | $0.00 derived: sum of 3 quarters · filed 2014-02-26 | $0.00 10-K · filed 2014-02-26 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $0.00 derived: sum of 2 quarters · filed 2011-10-31 | $0.00 10-Q · filed 2011-10-31 | $0.00 derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $0.00 10-Q · filed 2011-08-01 | $0.00 derived: sum of 3 quarters · filed 2013-02-26 | $18.83M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $0.00 10-Q · filed 2011-04-29 | $0.00 derived: sum of 2 quarters · filed 2013-02-26 | $18.83M derived: sum of 3 quarters · filed 2013-02-26 | $18.83M derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $18.83M derived: sum of 2 quarters · filed 2013-02-26 | $18.83M derived: sum of 3 quarters · filed 2013-02-26 | $32.95M 10-K · filed 2013-02-26 |
| 2010-09-30 | $18.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $18.83M derived: sum of 2 quarters · filed 2011-10-31 | $32.95M 10-Q · filed 2011-10-31 | $50.47M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $14.12M 10-Q · filed 2011-08-01 | $31.64M derived: sum of 3 quarters · filed 2012-02-22 | $31.64M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | $14.12M 10-Q · filed 2011-04-29 | $31.64M derived: sum of 2 quarters · filed 2012-02-22 | $31.64M derived: sum of 3 quarters · filed 2012-02-22 | |
| 2009-12-31 | $17.52M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $17.52M derived: sum of 2 quarters · filed 2012-02-22 | $17.52M 10-K · filed 2012-02-22 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $0.00 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $0.00 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | $0.00 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |